SIGA Technologies, Inc. stock rating and score history
All changes in ratings, performance and outlook tracked over time.
SIGA Technologies, Inc. stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does SIGA Technologies, Inc. do? Business model and key facts
Get the full picture of SIGA Technologies, Inc.: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees (FY): 46
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Stocks related to SIGA Technologies, Inc.
Selected based on industry alignment and relative market positioning.
Events and news impacting SIGA Technologies, Inc. stock
Earnings, coporate decisions and industry developments that can affect the share price.
SIGA Technologies, Inc. fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
